抑制剂简介
抑制剂是一类能够降低或阻止生物体内的酶活性、受体的活性或是细胞内特定反应过程的小分子化合物。它们在有机化学、化学化工和生物医药领域中有着广泛的应用,尤其是在药物研发方面。
分类与作用机制
应用领域
总结
抑制剂的研究和发展对于理解生命过程至关重要,并在药物开发、基础科学研究等多个领域发挥着重要作用。随着技术的进步,新的抑制剂不断被发现和开发出来,为医学治疗提供了更多的可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid | 149709-62-6 | C24H29NO5 |
|
—— | DL-nebivolol hydrochloride | 152520-56-4 | C22H25F2NO4*ClH |
|
—— | 2-(4-ethylpiperazin-1-yl)-N-(4-(2-morpholino-4-oxo-4H-chromen-8-yl)dibenzo[b,d]thiophen-1-yl)acetamide | 881375-00-4 | C33H34N4O4S |
|
—— | Trimethyl-[2-[4-oxo-4-[2-(trimethylazaniumyl)ethoxy]butanoyl]oxyethyl]azanium;chloride;hydrate | 6101-15-1 | C14H32ClN2O5+ |
|
—— | Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-,hydrochloride, dihydrate, (5a)- | 51481-60-8 | C19H24ClNO5 |
|
—— | Blasticidine S hydrochloride | 3513-03-9 | C17H27ClN8O5 |
|
—— | methyl (4aS,6aR,6bS,12aS,14aR,14bR)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6,7,8,8a,14a,14b-decahydropicene-4a-carboxylate | 218600-53-4 | C32H43NO4 |
|
—— | CCI-779 | 162635-04-3 | C56H87NO16 |
|
—— | (3S,4R,5R,8R,9Z,12R,14S,15R,16S,18R,19R,26aS)-8-allyl-5,19-dihydroxy-3-{(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylvinyl}-14,16-dimethoxy-4,10,12,18-tetramethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone | 104987-11-3 | C44H69NO12 |
|
—— | Antibiotic S 7481F1 | 59865-13-3 | C62H111N11O12 |
|
—— | 4-Pyrimidinamine, 6-(4-methyl-1-piperazinyl)-N-(5-methyl-1H-pyrazol-3-yl)-2-((1E)-2-phenylethenyl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) | 934353-76-1 | C25H31N7O6 |
|
—— | [(Z)-4-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-3-[[(E)-2-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-5-(2-methylpropanoyloxy)pent-2-en-3-yl]disulfanyl]pent-3-enyl] 2-methylpropanoate | 3286-46-2 | C32H46N8O6S2 |
|
—— | Nacubactam monohydrate | 2007923-17-1 | C9H18N4O8S |
|
—— | N-[(3S,6S,12R,15S,16R,19S)-25-[[(3S)-1-azabicyclo[2.2.2]octan-3-yl]sulfanylmethyl]-3-[[4-(dimethylamino)phenyl]methyl]-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide | 120138-50-3 | C53H67N9O10S |
|
—— | 8-Azaspiro[4.5]decane-7,9-dione, 8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-, hydrochloride (1:2) | 21102-95-4 | C22H32ClN3O3 |
|
—— | (1R,9S,12S,13R,14R,17R,18Z,21R,23S,24R,25S,27R)-1,14-Dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone | 104987-11-3 | C44H69NO12 |
|
—— | Nelfinavir mesylate hydrate | 159989-65-8 | C33H51N3O8S2 |
|
—— | Taniborbactam | 1613267-49-4 | C19H28BN3O5 |
|
—— | Pco-371 | 1613373-33-3 | C29H32F3N5O6S |
|
—— | (2S,3S)-2-(dimethylamino)-N-[(2S)-2-[[(3R,5S)-3-methoxy-1-[(2S)-2-[(2R)-1-methoxy-2-methyl-3-oxo-3-[[(1R)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methylbutanoyl]-3-methylpentanamide | 212007-18-6 | C43H70N6O6S |
|
—— | 2-[3-(2,6-Dimethylpiperazin-1-yl)phenyl]-2-phenylpentanamide | 149838-21-1 | C23H31N3O |
|
—— | {[4-phenyl-1-(4-(2-quinolinylmethoxy)phenyl)butyl]thio}acetic acid | 127481-29-2 | C28H27NO3S |
|
—— | Sulbutiamine | 3286-46-2 | C32H46N8O6S2 |
|
—— | (1S,4S,10S,21R)-7-Ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone | 128517-07-7 | C24H36N4O6S2 |
|
—— | Azanide;2-hydroxyacetic acid;platinum(2+) | 95734-82-0 | C2H8N2O3Pt |
|
—— | Histamine Phosphate | 51-74-1 | C5H15N3O8P2 |
|
—— | Cisatracurium Besylate | 96946-42-8 | C65H82N2O18S2 |
|
—— | N,N,N,2-Tetramethyl-5-(1-methylethyl)-4-((1-piperidinylcarbonyl)oxy)benzenaminium chloride | 2438-53-1 | C19H31ClN2O2 |
|
—— | 4-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-N-(2-methyl-1-(2-(1-methylpiperidin-4-yl)phenyl)propan-2-yl)-6-morpholino-1,3,5-triazin-2-amine | 1401436-95-0 | C31H38F2N8O |
|
—— | lubiprostone | 136790-76-6 | C20H32F2O5 |
|
—— | (2S)-1-[(2S)-2-[(2-aminoacetyl)amino]-3-(1H-indol-3-yl)propanoyl]-N-[2-[[(2S)-1-[[2-[[(1R,2S)-1-hydroxy-1-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-3-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,3-dihydropyrrole-2-carboxamide | 151928-32-4 | C41H52N8O9 |
|
—— | PIK-90 | 677338-12-4 | C18H17N5O3 |
|
—— | MK2206 dihydrochloride | 1032350-13-2 | C25H21N5O*2ClH |
|
—— | 3-amino-N-(5-(4-(2,3-dichlorophenyl)piperazin-1-yl)pentyl)-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide | 1610591-93-9 | C25H31Cl2N5OS |
|
—— | 6-amino-8-trifluoromethylphenanthridine | 651055-83-3 | C14H9F3N2 |
|
—— | (2Z)-3-amino-3-[(4-aminophenyl)sulfanyl]-2-[2-(trifluoromethyl)phenyl]prop-2-enenitrile | 305350-87-2 | C16H12F3N3S |
|
—— | Akt Inhibitor V, Triciribine | 35943-35-2 | C13H16N6O4 |
|
—— | Velneperit | 342577-38-2 | C17H24F3N3O3S |
|
—— | Panzem NCD | 362-07-2 | C19H26O3 |
|
—— | Ethyl(2s,3s)-3-[[1-(isopentylcarbamoyl)-3-methyl-butyl]carbamoyl]oxirane-2-carboxylate | 88321-09-9 | C17H30N2O5 |
|
—— | 2-(2-Acetamido-4-methylvaleramido)-N-(1-formyl-4-guanidinobutyl)-4-methylvaleramide | 24365-47-7 | C20H38N6O4 |
|
—— | 6-Bromoindirubin-3'-oxime | 667463-62-9 | C16H10BrN3O2 |
|
—— | 2-((4-(1-[11C]methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl)phenoxy)methyl)quinoline | 1292799-56-4 | C25H20N4O |
|
—— | trans-4-{4-[7-amino-2-(1,2,3-benzothiadiazol-7-yl)-3-chlorofuro[2,3-c]pyridin-4-yl]-1H-pyrazol-1-yl}cyclohexanol | 1326712-16-6 | C22H19ClN6O2S |
|
—— | N-[(3S,6S,15S,16R,19S,25R)-25-[[(3S)-1-azabicyclo[2.2.2]octan-3-yl]sulfanylmethyl]-3-[[4-(dimethylamino)phenyl]methyl]-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide | 120138-50-3 | C53H67N9O10S |
|
—— | 4-Benzyl-1-(beta,4-dihydroxy-alpha-methylphenethyl)piperidinium hydrogen tartrate | 23210-58-4 | C46H60N2O10 |
|
—— | C646 | 328968-36-1 | C24H19N3O6 |
|
—— | Rilzabrutinib, (Z)- | 1575596-29-0 | C36H40FN9O3 |
|
—— | Bax channel blocker | 335165-68-9 | C19H21Br2N3O |
|
—— | (4-(5-amino-6-(4-(trifluoromethyl)phenyl)pyrazin-2-yl)-phenyl)(piperazin-1-yl)methanone | 1450666-80-4 | C22H20F3N5O |
|